American Society of Pharmacovigilance | Strategic Alliance Partners
ASP is a national biomedical and healthcare network with membership open to all healthcare professions. As a 501(c)(3) nonprofit organization, ASP is dedicated to rapidly and dramatically reducing the high rate of suffering and mortality created by a wide variety of adverse drug events in the United States. ASP represents a unity of different areas of expertise coming together to address and eliminate the fourth leading cause of death in the nation and is the only organization uniformly focused on preventing adverse drug events.
Latest from American Society of Pharmacovigilance
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards
November 25th 2024Raymond Lorenz, PharmD, BCPP, discusses the role of pharmacists in bridging laboratory results and clinical practice, highlighting ongoing efforts to establish pharmacogenomic testing standards and foster multidisciplinary collaboration for broader clinical impact.
Watch
STRIPE Annual Meeting: Standardizing Clinical Utility in Pharmacogenetics
November 25th 2024Jai N. Patel, PharmD, BCOP, CPP, discussed efforts to standardize the evaluation of clinical utility in pharmacogenetics, emphasizing its variability, the role of pharmacogenomics in research, and the importance of robust study designs for pharmacy professionals.
Watch
Advancing Pharmacogenomics Education: Standardization and Opportunities in Pharmacy
November 19th 2024Christine Formea, PharmD, MHI, BCPS, FCCP, FASHP, discusses the need for standardized pharmacogenomics education in pharmacy, highlighting opportunities for collaboration, professional growth, and integration of key competencies across curricula to advance the profession.
Watch
Sara Rogers, PharmD, discusses the formation and goals of the Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) initiative, which seeks to standardize pharmacogenomic practices and improve clinical decision-making by establishing consensus across all stakeholders.
Watch
Ryan Nelson, PharmD, discusses the STRIPE Annual Meeting and Consensus Workshop’s focus on unifying pharmacogenetic guidelines across major organizations, such as the FDA, European Medicines Agency, Clinical Pharmacogenetics Implementation Consortium, and National Comprehensive Cancer Network.
Watch
Shaping the Future of Pharmacogenomics: STRIPE Drives Stakeholder Consensus at Inaugural Meeting
October 24th 2024Benjamin Brown of Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) discusses his own experience as a patient with cancer and how consensus around pharmacogenomic practices can improve the lives of patients.
Watch
Advancement in Stem Cell Transplantation: Improving Outcomes for Patients With Blood Cancer
Advances, challenges, and promising innovations emerge.
Read More
Managing Blood Glucose Levels for Expectant Mothers With Diabetes
CGM enhances diabetes management in pregnancy, improving outcomes.
Read More
Advancing Pharmacists’ Role in Personalized Treatment for Breast, Prostate, and Lung Cancer
Precision oncology represents an evolution in therapeutic practice.
Read More
The Blood Detective: Tackling Medication-Induced Hematological Disorders
These disorders can be fatal, making pharmacists’ role in detection crucial.
Read More
Give Your Patients Options for Managing Menstrual Pain
Recommendations range from contraceptives to heat therapy to holistic use of spices.
Read More
Managing Recurrent C difficile Infections: Past, Present, and Future
Since 2000, as the number of CDIs has surged, morbidity and mortality also have increased.
Read More
